CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Fungal nail infection (onychomycosis) - How up-to-date is this topic?
Previous changes
April 2008 — minor update to the text for oral ketoconazole, this now reflects the most recent Medicines and Healthcare products Regulatory Agency (MHRA) guidance.
March 2008 — minor update. New text inserted regarding rare cases of changes in INR when warfarin and oral terbinafine have been given concomitantly. Issued March 2008.
July 2006 — minor update. Amorolfine is now available to buy over-the-counter and the text has been amended to reflect this. Issued in July 2006.
October–December 2005 — written. Validated in March 2006 and issued in May 2006. This guidance superseded the PRODIGY guidance on Fungal (dermatophyte) infections — skin and nails and Candida — skin and nails, which were withdrawn.
© NHS Institute for Innovation and Improvement